O-Phosphono-D-threonine is a phosphonic acid derivative of the amino acid threonine, characterized by the presence of a phosphono group attached to the hydroxyl group of the threonine side chain. This compound is typically a white to off-white solid and is soluble in water due to its polar nature, which is attributed to the phosphonic acid functional group. O-Phosphono-D-threonine is often used in biochemical research, particularly in studies involving phosphorylation processes and signal transduction pathways. Its structure allows it to mimic natural substrates in enzymatic reactions, making it a valuable tool in the investigation of enzyme mechanisms and interactions. Additionally, the presence of the phosphono group can influence the compound's biological activity and stability, making it an interesting subject for further study in medicinal chemistry and drug design. As with many phosphonic acids, it may exhibit unique properties in terms of reactivity and interaction with biological systems, warranting careful handling and consideration in experimental applications.

O-phosphono-D-threonine

Find at CymitQuimica all products linked to CAS 96193-69-0. Enter now to get more information

D-O-Phospho Threonine

D-O-Phospho threonine is a molecule that has been shown to have potential as a therapeutic agent for cancer treatment. It has been demonstrated to have biphasic effects, with low concentrations inhibiting tumor growth and high concentrations inducing apoptosis. D-O-Phospho threonine binds to intracellular targets and inhibits angiogenesis, which may be one of the mechanisms by which it acts as an anti-tumor agent. This drug also modulates the immune system, suppressing T cell proliferation and enhancing natural killer cell activity. D-O-Phospho threonine is biofunctional and has been shown to inhibit human liver cells in culture. This molecule can also be used as a model organism in cell culture studies.br> D-O-Phospho threonine is a molecule that has been shown to have potential as a therapeutic agent for cancer treatment. It has been demonstrated to have biphasic effects, with low concentrations

CAS 96193-69-0: O-phosphono-D-threonine

D-O-Phospho Threonine

Ref: 7W-GM5901

D-O-Phospho Threonine

Ref: TR-P364500

D-O-Phospho threonine

Ref: 3D-FP27015